Showing results (91-100 of 196) with videos related to

Sort By:
Pageof 20
Cureus|October 28, 2024
A Rare Case of Hemodialysis as an Extracorporeal Treatment for Severe Phenytoin OverdoseRandy Felber, Victoria R Prager, Deena Werde, et al.
Diabetes, Obesity & Metabolism|July 23, 2008
Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trialA Liebl, R Prager, K Binz, et al.
World Journal of Surgery|July 1, 1992
Primary hyperparathyroidism in Austria: results of an 8-year prospective studyB Niederle, L Stamm, F Längle, et al.
Experimental and Clinical Endocrinology|August 1, 1990
Decreased peripheral insulin sensitivity in acromegalic patientsA Luger, R Prager, S Gaube, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1989
Persistently low immunoreactive and normally bioactive plasma LH during male pubertyZ Dickerman, R J Barkey, R Prager-Lewin, et al.
Archives of Surgery (Chicago, Ill. : 1960)|March 1, 1976
An experience with a LeVeen ascites shuntJ Holcroft, H Y Kressel, R Prager, et al.
British Journal of Pharmacology|January 22, 2009
Incomplete dissociation of glibenclamide from wild-type and mutant pancreatic K ATP channels limits their recovery from inhibitionU Russ, P Kühner, R Prager, et al.
Acta Endocrinologica|July 1, 1977
Plasma LH and FSH response to LRH and plasma testosterone levels in boys with irregular pubertyZ Dickerman, Y Bar-Haim, R Prager-Lewin, et al.
Cardiovascular and Interventional Radiology|December 7, 2013
Dual-energy CT immediately after endovascular stroke intervention: prognostic implicationsD Morhard, L Ertl, W Gerdsmeier-Petz, et al.
Atherosclerosis|June 1, 1982
Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabeticsR Prager, G Schernthaner, G M Kostner, et al.
Pageof 20